Dangerous blood clots increased with newer antipsychotic drugs

Sep 23, 2010

Taking newer types of antipsychotic drugs could increase a person’s risk of developing dangerous blood clots, according to a new University of Nottingham study published on bmj.com today.

Venous thromboembolism — a collective term for deep vein and — is an important and preventable cause of illness and death. Up to a quarter of affected patients die within a week and almost a third of survivors experience long-term effects.

There is already limited evidence that antipsychotic drugs, some of which are also prescribed for nausea, vomiting and vertigo, may be associated with an increased risk of .

Previous studies, however, have been small and restricted to certain population groups, or have not included newer ‘atypical’ antipsychotic drugs.

Researchers from The University of Nottingham and the Nottinghamshire County Teaching Primary Care Trust examined how these drugs affected people taking them, looking at the type of drug used, and the potency and dose involved.

Data for this study came from the UK QResearch primary care database, which holds the anonymised primary care clinical records of more than 11 million people registered at any time in the past 16 years with 525 UK general practices.

The Nottingham researchers, led by Professor Julia Hippisley-Cox at The University of Nottingham, looked at 25,532 eligible cases — 15,975 with and 9,557 pulmonary embolism — recorded between 1996 and 2007 in people aged between 16 and 100.

The cases were compared with 89,491 controls and showed that people prescribed antipsychotics in the previous 24 months had a 32 per cent greater risk of venous thromboembolism than non-users, even after adjusting for potential risk factors.

Risks were higher for new users, the researchers found, as patients who had started a new drug in the previous three months, had about twice the risk.

The risk was even greater for individuals prescribed atypical rather than conventional drugs. It also tended to be greater for patients prescribed low rather than high potency drugs.

However, the authors point out that the absolute risks were low, with an excess of four extra cases of venous thromboembolism per 10,000 patients treated over one year in patients of all ages, and 10 for patients aged 65 and over.

They conclude: “Though these findings add to the accumulating evidence of adverse health events associated with antipsychotic drugs, they should be confirmed with other data sources.

“If other studies replicate these findings, antipsychotic drugs should be used more cautiously for nausea and agitation etc, especially among patients at high risk of thromboembolism. Patients need information on the balance of risks and benefits of these drugs before they start treatment.”

In an accompanying editorial, geriatrics experts Rosa Liperoti and Giovanni Gambassi argue that a higher risk means treatment should be tailored according to individual risk factors.

“In clinical practice we need to be able to identify the best candidates for antipsychotic treatment … and those who may be more susceptible to developing side effects as a result of individual vascular risk factors possibly interacting with antipsychotics,” they say.

Explore further: Drug research and development more efficient than expected

More information: URL for the paper: www.bmj.com/cgi/doi/10.1136/bmj.c4245

add to favorites email to friend print save as pdf

Related Stories

Bowel disease link to blood clots

Feb 10, 2010

People living with Inflammatory Bowel Disease (IBD) are known to be at high risk of blood clots when admitted to hospital during a flare-up of their disease but now new research by scientists at The University of Nottingham ...

Recommended for you

Drug research and development more efficient than expected

12 hours ago

Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could ...

Use new meningitis vaccines only for outbreaks

Feb 26, 2015

(AP)—A U.S. panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.

New antibiotic avycaz approved

Feb 26, 2015

(HealthDay)—The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract, ...

Tagging drugs to fight counterfeit medicines

Feb 25, 2015

The U.S. and other countries are enacting rules to clamp down on the sales of fake pharmaceuticals, which pose a public health threat. But figuring out a system to track and authenticate legitimate drugs still faces significant ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.